Use our pre-submission checklist
Avoid common mistakes on your manuscript.
1 Correction to: Drugs https://doi.org/10.1007/s40265-020-01311-1
In the table ‘Key clinical trials of isatuximab (Sanofi)’, in the left-hand column:
The first row, which currently reads ‘Isatuximab, bortezomib, lenalidomide, dexamethasone’.
Should read ‘Isatuximab, pomalidomide, dexamethasone’.
The third row, which currently reads ‘Isatuximab, pomalidomide, dexamethasone’.
Should read ‘Isatuximab, bortezomib, lenalidomide, dexamethasone’.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dhillon, S. Correction to: Isatuximab: First Approval. Drugs 80, 913 (2020). https://doi.org/10.1007/s40265-020-01325-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40265-020-01325-9